Registry-based study on the effect and safety of Cre8™, Cre8 Evo ™, Amphilimus -eluting stent for coronary atherosclerotic lesions
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0008521
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Over 19 years of age who has been treated with a Cre8™ and Cre8 Evo ™ , stent for coronary artery disease who has agreed in writing to participate in this registry study
Exclusion Criteria
Pregnant women, lactating women, or women of childbearing age who are planning to conceive are excluded.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method combined clinical events of Death, Myocardial infarction and Target Vessel Revascularization(TVR)
- Secondary Outcome Measures
Name Time Method cardiogenic death;myocardial infarction;stent thrombosis;bleeding events